GlassScriptPhysician profile
Mohamad Kabbani
NPI 1114997822
$1,344.25
in general payments reported to CMS, 2019-2025
16 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.66 · 2021: $101 · 2022: $102 · 2023: $350 · 2024: $441 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $503.76 | 2023-2024 | Lifevest |
| Abiomed | $213.91 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.14 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $92.12 | 2024-2025 | Camzyos |
| Boston Scientific Corporation | $77.57 | 2023 | |
| Cordis US Corp. | $58.64 | 2024-2025 | Mynxgrip |
| Edwards Lifesciences Corporation | $58.08 | 2022 | |
| Biosense Webster, INC. | $47.62 | 2023 | Carto 3 |
| Abbott Laboratories | $40.24 | 2022-2023 | Pressurewire |
| Philips North America LLC | $30.79 | 2023 | (5044) Mcot |
| Novartis Pharmaceuticals Corporation | $27.11 | 2019-2024 | |
| Pfizer INC. | $24.34 | 2025 | |
| Chiesi USA, INC. | $23.26 | 2022 | |
| Zoll Circulation INC | $18.70 | 2024 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Astrazeneca Pharmaceuticals LP | $13.82 | 2023 | Farxiga |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $13.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamad Kabbani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.